South Korea Expands Open Innovation Support for Startups

CHA Biotech plans to allocate 10,000 square meters within its CGB facility to the K-Bio-CIC Open Innovation Center, with full-scale operations expected to begin in the second half of 2026, according t

MH
Marcus Havel

May 19, 2026 · 3 min read

Futuristic Seoul cityscape with holographic DNA and startup logos, symbolizing South Korea's expanding open innovation for biotech startups.

CHA Biotech plans to allocate 10,000 square meters within its CGB facility to the K-Bio-CIC Open Innovation Center, with full-scale operations expected to begin in the second half of 2026, according to KBR. CHA Biotech's plan to allocate 10,000 square meters within its CGB facility to the K-Bio-CIC Open Innovation Center, with full-scale operations expected to begin in the second half of 2026, according to KBR, is a direct strategy to integrate international expertise and accelerate advanced biotech R&D.

South Korea has historically nurtured a strong domestic startup ecosystem. However, its next phase of growth is increasingly reliant on actively integrating global partners and capital. This shift is crucial for startups seeking broader market access and advanced R&D opportunities.

South Korea is poised to become a more significant global hub for collaborative innovation, attracting international players and propelling its startups onto the world stage. This strategy involves targeted government funding and corporate initiatives designed to embed its startups directly into international R&D and market ecosystems, expanding South Korea's startup open innovation support by 2026.

A New Hub for Biotech Innovation

CHA Biotech and Thermo Fisher are partnering to build and operate the K-Bio CIC research hub, according to Seoul Economic Daily. Located within CHA Biotech's CGB facility—a 10-story aboveground and 4-story underground building spanning 66,115 square meters, according to KBR—this dedicated space confirms the scale of South Korea's biotech ambition.

The K-Bio CIC research hub will provide tenant firms with tech validation and clinical trial support, according to Seoul Economic Daily. This comprehensive support structure, combined with the substantial physical infrastructure, creates a robust ecosystem designed for biotech startups to scale and innovate. By co-investing in massive, sector-specific hubs like the 10,000 square meter K-Bio-CIC with global partners like Thermo Fisher, South Korea is not just inviting foreign collaboration but actively building the physical infrastructure to embed its strategic industries into the global R&D landscape by 2026.

Mobility Leaders Go Global

Hyundai Mobis held its fifth Mobis Mobility Day in Silicon Valley to expand collaboration in robotics and physical AI with global partners, according to The Korea Herald. This annual event serves as a critical platform for identifying and engaging with international innovators.

This year's Mobis Mobility Day event drew around 400 participants, more than double last year's attendance, according to The Korea Herald. The Mobis Mobility Day event drawing around 400 participants, more than double last year's attendance, according to The Korea Herald, confirms global interest in Korean mobility tech and underscores the strategic value of international partnerships for giants like Hyundai Mobis. Major Korean conglomerates are not just participating; they are leading their own aggressive global outreach.

Government Fuels Overseas Expansion

The GAPS program, supporting 72 startups in its pre-program, commands KRW 38.495 billion, according to kised. The GAPS program, supporting 72 startups in its pre-program and commanding KRW 38.495 billion, according to kised, confirms a national commitment to fostering international growth for its startup sector.

The Overseas Expansion Fund can cover travel expenses, HR & PR expenses, patent application fees, and incorporation fees, up to KRW 80 million, according to kised. These detailed subsidies directly lower barriers for startups, enabling them to meet complex requirements for global programs like Horizon Europe, which often demand multi-partner consortia. South Korea's government isn't just funding startups; it's actively subsidizing the mechanisms for global integration.

The Path Ahead for Korean Innovation

With the K-Bio CIC set for full operation by late 2026, according to KBR, and Hyundai Mobis expanding its global outreach with a second Mobility Day in Asia this year, according to The Korea Herald, South Korea's multi-faceted push is clear. South Korea's multi-faceted push, backed by the KRW 38.495 billion GAPS program, signals a national pivot: the future of Korean innovation is explicitly global, not merely domestically focused.

If these strategic investments and global outreach efforts continue to mature, South Korea appears poised to solidify its position as a critical node in the global innovation network, attracting further international capital and talent.